SFGP
OGN icon

Stonebridge Financial Group (Pennsylvania)’s Organon & Co OGN Stock Holding History

Stonebridge Financial Group (Pennsylvania)’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-419
Closed -$6.24K – 699
2025
Q1 		$6.24K Sell
419
-251
-37% -$3.86K ﹤0.01% 669
2024
Q4 		$10K Buy
+670
New +$10.9K ﹤0.01% 594

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Stonebridge Financial Group (Pennsylvania)'s OGN Position: Q2 2025 in Review

Stonebridge Financial Group (Pennsylvania) sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 419 shares — an estimated $6.24K sold.

Stonebridge Financial Group (Pennsylvania) first reported a position in OGN in Q4 2024 and held it in 2 quarters. The position peaked at $10K in Q4 2024. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Stonebridge Financial Group (Pennsylvania) reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Stonebridge Financial Group (Pennsylvania) sold 419 Organon & Co shares in Q2 2025, an estimated $6.24K.
  • Stonebridge Financial Group (Pennsylvania) first reported a position in Organon & Co in Q4 2024 and held it in 2 quarters.
  • Stonebridge Financial Group (Pennsylvania)'s Organon & Co position peaked at $10K in Q4 2024.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Stonebridge Financial Group (Pennsylvania)'s 13F filing for Q2 2025, filed 24 Jul 2025.